Seres Therapeutics (MCRB) Interest Coverage Ratio (2020 - 2024)
Historic Interest Coverage Ratio for Seres Therapeutics (MCRB) over the last 5 years, with Q1 2024 value amounting to 55.72.
- Seres Therapeutics' Interest Coverage Ratio fell 5382.63% to 55.72 in Q1 2024 from the same period last year, while for Dec 2024 it was 196.3, marking a year-over-year decrease of 88194.47%. This contributed to the annual value of 79.05 for FY2023, which is 16450.69% down from last year.
- Per Seres Therapeutics' latest filing, its Interest Coverage Ratio stood at 55.72 for Q1 2024, which was down 5382.63% from 15.54 recorded in Q2 2023.
- Over the past 5 years, Seres Therapeutics' Interest Coverage Ratio peaked at 91.94 during Q3 2021, and registered a low of 66.98 during Q4 2021.
- Its 5-year average for Interest Coverage Ratio is 28.48, with a median of 36.23 in 2023.
- Examining YoY changes over the last 5 years, Seres Therapeutics' Interest Coverage Ratio showed a top increase of 32376.99% in 2021 and a maximum decrease of 18404.63% in 2021.
- Quarter analysis of 5 years shows Seres Therapeutics' Interest Coverage Ratio stood at 23.58 in 2020, then crashed by 184.05% to 66.98 in 2021, then soared by 98.63% to 0.92 in 2022, then soared by 1787.7% to 15.54 in 2023, then crashed by 458.6% to 55.72 in 2024.
- Its last three reported values are 55.72 in Q1 2024, 15.54 for Q2 2023, and 36.23 during Q1 2023.